Physician profile
James Sutherland
NPI 1811982945
$2,774.07
in general payments reported to CMS, 2019-2025
20 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $814 · 2020: $232 · 2021: $432 · 2022: $434 · 2023: $307 · 2024: $440 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,083.49 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $487.22 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Regranex |
| W. L. Gore & Associates, INC. | $324.30 | 2019-2021 | |
| Organogenesis INC. | $207.09 | 2021-2024 | Puraply |
| Medtronic Vascular, INC. | $176.40 | 2019 | |
| Paratek Pharmaceuticals, INC. | $116.47 | 2021-2024 | Nuzyra |
| Integra Lifesciences Corporation | $54.56 | 2019-2025 | Tcc-Ez |
| Solventum Corporation | $46.01 | 2025 | Activ.A.C., 3m Coban |
| Cashflow Solutions, LLC | $44.37 | 2022-2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Kci USA, INC. | $31.69 | 2019-2023 | Activ.A.C. |
| Pacira Pharmaceuticals Incorporated | $31.19 | 2020-2021 | |
| Ovik Health, LLC | $30.40 | 2023-2024 | Coflex Tlc |
| Checkpoint Surgical, INC | $28.04 | 2019-2021 | |
| Next Science LLC | $22.73 | 2022 | |
| Cook Medical LLC | $19.98 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17.48 | 2019 | |
| Reprise Biomedical, INC. | $16.98 | 2025 | Miro3d |
| Lemaitre Vascular, INC. | $13.91 | 2019 | |
| Shire North American Group INC | $12.43 | 2019 | |
| Thd America, INC. | $9.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sutherland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.